BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

InnaVirVax 

4 rue Pierre Fontaine

  Evry Cedex    France
Phone: 33-0-1-80-85-60-83 Fax: 33-0-1-80-85-60-87


SEARCH JOBS










 Company News
InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used In Combination With Standard Antiretroviral Therapy In Treatment Of HIV-Infection 12/2/2013 11:23:28 AM    More...
InnaVirVax Announces Presentation of the Results of Its Phase I/IIa Clinical Study at CROI 2013 in Atlanta 3/5/2013 2:59:22 PM    More...
InnaVirVax Announces Publication of an Article in JAIDS (Journal of Acquired Immune Deficiency Syndromes) 3/1/2013 11:41:12 AM    More...
InnaVirVax: the Phase I/IIa Clinical Study of Its VAC-3S Immunotherapeutic Vaccine in the Treatment of HIV Infection Has Achieved Its Primary Endpoint 11/30/2012 1:41:55 PM    More...
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy 6/18/2012 11:46:37 AM    More...
InnaVirVax Announces the Launch of the First Clinical Trial on VAC-3S, a Novel Immunotherapy for the Treatment of HIV-1 Infections 3/5/2012 9:19:53 AM    More...